Brand versus generic medications: A disease state approach to identify patients’ perceptions and concerns

Abstract

Background Medication cost does not solely dictate patient preference of brand name or generic medications. However, few studies have been completed to assess the influence of other factors, such as demographics and chronic diseases. Methods Responses were collected from 347 English speaking adults in the United States, age 18 and older, pertaining to demographics, diagnosed conditions, preference and knowledge of brand and generic medications. Results Participants with COPD, epilepsy, and high cholesterol felt that their condition influenced their preference of brand or generic medication more as compared with participants diagnosed with other conditions. If cost was not an issue, then 46% of respondents would prefer the brand name product, while 18% of participants felt their preference depended on the condition that the medication was intended to treat. Roughly one-third of the participants did not fully understand why there are both brand name and generic medications, and education level did not impact comprehension significantly. Conclusion The incentive for generic preference over brand name is primarily due to cost differences. However, improvement of education pertaining to brand/generic equivalency is needed, as some patients still believe brand name medications are superior to generic alternatives for certain disease states.

Influencers of generic drug utilization: A systematic review

“…While many patients have reported taking a generic drug, many perceive generic drugs as less effective or safe than brand name equivalents. 86, 87 Patients’ perceptions about generic drugs may ultimately influence prescribing and dispensing patterns. According to results from a national survey of U.S. physicians with a variety of specialties, more than one-third of respondents indicated that, when requested by patients, they often or sometimes prescribed brand-name drugs when appropriate generic substitutes were available.…”

Green on What Side of the Fence? Librarian Perceptions of Accepted Author Manuscripts

“…A three-part scale of preference for "Accepted Author Manuscript," "Publisher Final Edited Version," and "No Preference" was used across a core set of questions that asked about specific research contexts. This scale was adapted from a previous study dealing with consumer preference between brand-name and generic drugs (Smith, Mosley, Ford, Courtney, & Stefanelli, 2015). The generic and brand-name drug scale resonated in part as a potential metaphor for AAM and publisher versions.…”

E.P.A.S.S: Electroanalytical Pillbox Assessment Sensor System, A Case Study Using Metformin Hydrochloride

“…Medications have played an important and significant role in human survival, which includes a vast array of treatments for a myriad of chronic and acute conditions. , The total use of medications in 2020 has reached 4.5 trillion doses, up 24% from 2015 levels, mostly consumed by India, China, Brazil, and Indonesia. Well-established consumer markets continue to use more original branded and specialty medicines per capita, while pharma markets in developing countries are expected to use more nonoriginal brands, generics, and over-the-counter products. − It has been a common perception that illicit drugs typically contain excipient nonregulated substances, in addition to the active ingredient, which can have serious adverse health consequences or even cause premature death. ,− Typical adulterant items include mannitol, sugar, gravy powder, chalk powder, brick dust, and so forth. , This form of adulteration is currently considered to be a significant problem and can only be resolved by intensive chemical testing. Metformin is a common drug for type (II) diabetes.…”